|

Smith & Nephew is a leading portfolio medical technology company, operating in over 100 countries globally.
Our purpose
Life Unlimited. Smith & Nephew exists to restore people’s bodies, and their self-belief. Our ENT portfolio features:
COBLATION Plasma Technology: A minimally invasive, low thermal technology for effective dissection and removal of tissue. Introducing our ARIS COBLATION Turbinate Reduction Wand for targeted tissue removal and hemostasis at your fingertips.
RAPID RHINO: Technology Features a wide range of dissolvable and removable postoperative nasal dressings, as well as a comprehensive portfolio of epistaxis solutions.
|

Cura Day Hospitals Group is Australia’s leading provider of private day hospital facilities, proudly supporting over 1,160+ Specialists across a national network of 39 hospitals.
Our mission is to maintain modern, fully equipped hospitals that meet the highest safety and clinical standards, allowing Specialists to focus entirely on delivering exceptional patient care. Our hospitals are staffed by highly skilled clinical teams, and supported by cutting-edge technology.
Cura Day Hospitals Group maintains agreements with all major health insurers and offers competitive pricing for self-funded patients. We prioritise a seamless patient journey by working closely with Specialists’ rooms to ensure patients are well-prepared and supported throughout their surgical journey. With a reputation for clinical excellence, operational efficiency, and patient-centred care, Cura Day Hospitals Group continues to be the hospitals of choice for Otolaryngologists.
About Cura 2026
|